Acredit co-founder Professor Kjersti Flatmark and colleagues have published new findings showing that the use of mitomycin C with intraperitoneal chemotherapy (IPEC) during cytoreductive surgery doubled survival times and reduced tumour growth in a...
Acredit’s own Ida Storhaug Frøysnes successfully defended her thesis today. Entitled “Novel Therapeutic Approaches in Peritoneal Metastasis from Colorectal Cancer”, Ida’s thesis focused on the potential for use of novel immunotoxin payloads in the...
Acredit member Dr Kjersti Flatmark has received 6.58 million kroners in funding from the Norwegian Cancer Society (Kreftforeningen) to look into the reasons that some abdominal cancers spread far more aggressively than others. Dr...
Acredit member Ida Storhaug Frøysnes has successfully submitted her thesis entitled “Novel therapeutic approaches in peritoneal metastasis from colorectal cancer”. Ida submitted on the 9th August 2018, and is now awaiting a date for...
